Genomictree Inc. (KOSDAQ:228760)

South Korea · Delayed Price · Currency is KRW

13,870

-990 (-6.66%)

Aug 12, 2026, 3:30 PM KST

Genomictree Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,825	3,760	2,362	3,418	29,866	5,140
Revenue Growth	59.78%	59.17%	-30.89%	-88.55%	481.09%	314.87%
Gross Profit	837.6	699	-745.56	-301.62	24,974	2,499
Operating Income	-10,599	-11,298	-15,313	-17,303	2,405	-9,855
Net Income	-8,024	-8,986	-10,242	-8,756	-6,631	-11,425
Earnings Per Share	-333.36	-374.27	-429.00	-448.80	-316.00	-553.38
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	75,385	77,366	96,080	93,146	114,605	130,542
Total Debt	55.19	2,368	2,079	1,835	29,180	38,444
Net Cash (Debt)	75,330	74,998	94,001	91,312	85,425	92,098
Net Cash Growth	-17.98%	-20.21%	2.94%	6.89%	-7.25%	0.57%
Net Cash Per Share	3129.59	3123.84	3937.19	3444.88	4069.68	4461.03

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-10,637	-10,193	-13,633	-10,881	4,286	-7,631
Capital Expenditures	-2,802	-2,726	-2,484	-239.08	-1,762	-10,963
Free Cash Flow	-13,439	-12,919	-16,118	-11,120	2,523	-18,593
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	21.90%	18.59%	-31.56%	-8.82%	83.62%	48.62%
Operating Margin	-277.10%	-300.47%	-648.24%	-506.25%	8.05%	-191.75%
Pretax Margin	-213.27%	-242.38%	-439.79%	-278.04%	-12.37%	-222.27%
Profit Margin	-209.77%	-238.98%	-433.57%	-256.17%	-22.20%	-222.28%
FCF Margin	-351.32%	-343.58%	-682.29%	-325.32%	8.45%	-361.76%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
P/FCF Ratio	-	-	-	-	71.93	-
PS Ratio	95.28	175.37	207.68	142.43	6.08	52.60